- Home
- Clinical Trials
Coeliac Disease Study Palmerston North DQB
Coeliac Disease Study
Palmerston North
This is your opportunity to support research aimed at advancing treatments for Coeliac Disease. We will be looking at how well a trial medication is tolerated and if it reduces the immune response to gluten. Your involvement could contribute to the development of more effective medications, ultimately enhancing the quality of life for individuals living with Coeliac Disease.
Description
What to expect
Study details
Ages
18 to 70 years old
Duration
29-day treatment period
Compensation
Participants will be reimbursed for study visits and reasonable study-related travel expenses.
Eligibility Criteria
You may be eligible to take part if you:
- Are aged 18 to 70 years of age.
- Have a biopsy-proven diagnosis or positive blood tests for Coeliac Disease
- Experienced relief from symptoms and been on a Gluten free diet for at least 12 months.
- Are willing to eat up to 10 grams of wheat gluten powder (between 2 and 3 slices of bread) each day, for 3 consecutive days during the study.
- Are willing to record symptoms in the provided electronic diary for 29 days.
Locations
Description
Momentum Clinical Research is conducting a research study to test a new investigational treatment for people with diagnosed coeliac disease who have experienced relief from symptoms after being on a gluten free diet for at least 12 months.
What to expect
Participants will receive the study treatment or placebo and then consume 10g of gluten powder (about 2 -3 slices of bread) each day, for three days. We'll be looking at how well the investigational treatment is tolerated and if it reduces the immune response to gluten.
After being approved to join the study, participants will be randomly assigned to receive a single dose of the study drug or a placebo (a harmless substance). Nine days after receiving the study treatment or placebo, participants will be given a wheat gluten powder every day for three days – equivalent to approximately 2 to 3 slices of bread per day. After that, participants will visit the clinic regularly until the study ends, The treatment period is 29 days and follow-up period till 176 days.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.